Pemafibrate treatment produces antidepressant-like effects in CUMS and CRS models through activation of hippocampal PPARα and BDNF signaling
International Journal of Neuropsychopharmacology · 2025
DOI: 10.1093/ijnp/pyaf063 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Jin Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Affiliated Hospital 2 of Nantong University, Nantong 226000, Jiangsu, China. Hauptthemen laut MEDLINE: PPAR alpha, Brain-Derived Neurotrophic Factor, Hippocampus, Stress, Psychological. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Scientific Research Project of Jiangsu Province, Jiangsu Provincial Health Commission, Research Project of Nantong Health Commission.
Abstract (Originalsprache)
Background
It is well established that peroxisome proliferator-activated receptor α (PPARα) plays a crucial role in the pathogenesis of depression. Several PPARα agonists, including WY14643, fenofibrate, and gemfibrozil, have been reported to produce antidepressant-like effects in mouse models through PPARα-mediated enhancement of hippocampal brain-derived neurotrophic factor (BDNF) signaling and neurogenesis. Pemafibrate is a novel and highly selective modulator of PPARα; we therefore hypothesized that it might also exhibit antidepressant-like efficacy.
Methods
We employed 2 established mouse models of depression, chronic unpredictable mild stress (CUMS) and chronic restraint stress (CRS), to evaluate the potential antidepressant effects of pemafibrate. Western blotting and immunofluorescence were used to assess whether pemafibrate treatment counteracts chronic stress-induced suppression of hippocampal PPARα, BDNF signaling, and neurogenesis. To investigate the mechanism of action, we utilized pharmacological inhibitors (GW6471 for PPARα and K252a for BDNF signaling) combined with adeno-associated virus–mediated genetic knockdown approaches.
Results
Repeated pemafibrate administration significantly ameliorated chronic stress-induced depressive-like behaviors and restored hippocampal PPARα levels, BDNF signaling, and neurogenesis in both models. These antidepressant effects were markedly attenuated by co-administration of GW6471 or K252a. Similarly, genetic knockdown of either hippocampal PPARα or BDNF abolished pemafibrate’s antidepressant-like actions.
Conclusions
Pemafibrate exerts antidepressant-like effects in both CUMS and CRS mouse models by promoting hippocampal PPARα and BDNF signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Affiliated Hospital 2 of Nantong University, Nantong 226000, Jiangsu, China.
- The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, Henan, China.
- Department of Rheumatology and Immunology, Affiliated Hospital 2 of Nantong University, Nantong 226000, Jiangsu, China.
- Department of Neurosurgery, Nantong Hospital of Traditional Chinese Medicine, Nantong 226009, Jiangsu, China.
- Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001, Jiangsu, China.
ORCID-Profile: Da-Wei Xu
Förderung
- Scientific Research Project of Jiangsu Province
- Jiangsu Provincial Health Commission
- Research Project of Nantong Health Commission
- Key Medical Talents Financial Assistance of Nantong
Zitieren
APA
Zhou, J., Zhao, W., Fan, H., Zhou, S. Y., Zhang, X. L., Xu, H., Jiang, B., Liu, W., Cui, Z. M., & Xu, D. W. (2025). Pemafibrate treatment produces antidepressant-like effects in CUMS and CRS models through activation of hippocampal PPARα and BDNF signaling. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf063
Vancouver
Zhou J, Zhao W, Fan H, Zhou SY, Zhang XL, Xu H, et al. Pemafibrate treatment produces antidepressant-like effects in CUMS and CRS models through activation of hippocampal PPARα and BDNF signaling. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf063
BibTeX
@article{Zhou2025,
author = {Zhou, Jin and Zhao, Wei and Fan, Hua and Zhou, Si-Yi and Zhang, Xiao-Li and Xu, Hui and Jiang, Bo and Liu, Wei and Cui, Zhi-Ming and Xu, Da-Wei},
title = {Pemafibrate treatment produces antidepressant-like effects in CUMS and CRS models through activation of hippocampal PPARα and BDNF signaling},
journal = {International Journal of Neuropsychopharmacology},
year = {2025},
doi = {10.1093/ijnp/pyaf063}
}
EUVIMED